CANNABIS SCHEDULING and PHARMACEUTICALS

/CANNABIS SCHEDULING and PHARMACEUTICALS
CANNABIS SCHEDULING and PHARMACEUTICALS 2017-04-18T12:32:54+00:00

DRUG SCHEDULING

  • Schedule I drug qualifications:
    • Intoxicating drug (altered mental and physiological states);
    • No accepted medical use;
    • High potential for abuse.
  • Cannabis and THC (and cannabis extracts) are listed as schedule I on Controlled Substances Act (CSA) I drugs
  • EXAMPLE – Schedule III Synthetic THC: Marinol® (24% of synthetic THC in sesame oil) is indicated as Antiemetic – Nausea and vomiting (patients undergoing cancer chemotherapy – Lymphomas), who have failed to respond to conventional antiemetic and appetite stimulant (patients with AIDS)
    • Pill form in 2.5, 5, or 10mg doses – maximum typically does not exceed six doses (60mg)/day
    • Contraindications: Anyone that has adverse reaction to THC or cannabis, or Marinol.
    • Psychotropic effects can last up to four hours and the
    • Major side effects
    • Mood changes, Dizziness, Drowsiness, Anxiety, Headache, Vomiting, Nausea,Sleep issues, Fainting
  • Plant-based medications
  • Sativex® (Canada and Europe) for MS, pain, spasticity, advanced cancer
  • Epidiolex® (plant-drived cannabidiol, stage III clinical trials; USA) for intractable seizures and epilepsies, Dravet syndrome, Lennox-Gastaut, Infantile spasms

 

Schedule 1 Schedule 2 Schedule 3
No accepted medical use High abuse potential Accepted use w/ restrictions High abuse potential Accepted medical use Some abuse potential
Cannabis Cesamet™ Marinol™
(THC, CBD) Cocaine Codeine
Heroin Opium Vicodin™
LSD, DMT Methadone Anabolic
MDMA PCP steroids

All content (C) 2017, Canntelligence.